Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Occupational Medicine (Oxford, England)
|
November 3, 2021
Shift work tolerance
J Degenfellner, E Schernhammer
Arzneimittel-Forschung
|
February 1, 1995
Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells
S Bandak, M Czejka, J Schüller, et al.
Die Pharmazie
|
June 1, 1995
[Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion]
M Czejka, J Schüller, E Schernhammer, et al.
Journal of Diabetes and Metabolic Disorders
|
November 16, 2023
Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment
J Dreier, E Schernhammer, H Haslacher, et al.
Experimental Gerontology
|
December 12, 2022
Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
Ines Elisabeth Futschek, E Schernhammer, H Haslacher, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
July 1, 1995
Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine
M Czejka, S Bandak, D Simon, et al.
British Journal of Cancer
|
March 10, 2005
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer
M Baur, E Schernhammer, M Gneist, et al.
Occupational Medicine (Oxford, England)
|
August 17, 2023
First-trimester occupational exposures and hypertensive disorders of pregnancy among US nurses
I Agarwal, S Wang, J Stuart, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
B Thürlimann, N Kröger, J Greiner, et al.
European Journal of Neurology
|
April 14, 2020
Increased risk of death associated with the use of proton-pump inhibitors in patients with dementia and controls - a pharmacoepidemiological claims data analysis
H Cetin, R Wurm, B Reichardt, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Occupational Medicine (Oxford, England)
|
November 3, 2021
Shift work tolerance
J Degenfellner, E Schernhammer
Arzneimittel-Forschung
|
February 1, 1995
Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells
S Bandak, M Czejka, J Schüller, et al.
Die Pharmazie
|
June 1, 1995
[Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion]
M Czejka, J Schüller, E Schernhammer, et al.
Journal of Diabetes and Metabolic Disorders
|
November 16, 2023
Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment
J Dreier, E Schernhammer, H Haslacher, et al.
Experimental Gerontology
|
December 12, 2022
Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
Ines Elisabeth Futschek, E Schernhammer, H Haslacher, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
July 1, 1995
Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine
M Czejka, S Bandak, D Simon, et al.
British Journal of Cancer
|
March 10, 2005
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer
M Baur, E Schernhammer, M Gneist, et al.
Occupational Medicine (Oxford, England)
|
August 17, 2023
First-trimester occupational exposures and hypertensive disorders of pregnancy among US nurses
I Agarwal, S Wang, J Stuart, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
B Thürlimann, N Kröger, J Greiner, et al.
European Journal of Neurology
|
April 14, 2020
Increased risk of death associated with the use of proton-pump inhibitors in patients with dementia and controls - a pharmacoepidemiological claims data analysis
H Cetin, R Wurm, B Reichardt, et al.
Page
of 2